Ironwood Pharmaceuticals (IRWD) Enterprise Value (2016 - 2025)
Ironwood Pharmaceuticals (IRWD) has disclosed Enterprise Value for 17 consecutive years, with -$184.3 million as the latest value for Q4 2025.
- Quarterly Enterprise Value fell 108.11% to -$184.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$184.3 million through Dec 2025, down 108.11% year-over-year, with the annual reading at -$184.3 million for FY2025, 108.11% down from the prior year.
- Enterprise Value hit -$184.3 million in Q4 2025 for Ironwood Pharmaceuticals, down from -$140.4 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$88.2 million in Q3 2024 to a low of -$741.6 million in Q1 2023.
- Historically, Enterprise Value has averaged -$326.0 million across 5 years, with a median of -$180.7 million in 2023.
- Biggest five-year swings in Enterprise Value: skyrocketed 85.98% in 2023 and later tumbled 108.11% in 2025.
- Year by year, Enterprise Value stood at -$621.4 million in 2021, then dropped by 5.81% to -$657.5 million in 2022, then surged by 85.98% to -$92.2 million in 2023, then rose by 3.9% to -$88.6 million in 2024, then crashed by 108.11% to -$184.3 million in 2025.
- Business Quant data shows Enterprise Value for IRWD at -$184.3 million in Q4 2025, -$140.4 million in Q3 2025, and -$92.9 million in Q2 2025.